TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33096986

Group type: EXPERIMENTAL
Intervention: Risk‐based methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment effect modeling methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimal treatment regime methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Model evaluation methods
Number of subjects: 0
Study: 36457360

Group type: EXPERIMENTAL
Intervention: Video-based cognitive behavioral therapy (CBT), 10 sessions over 12 weeks with a licensed clinical psychologist, using iPads via Apple FaceTime.
Number of subjects: 46

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 46
Study: 32216621

Group type: EXPERIMENTAL
Intervention: Group-based cognitive hypnotherapy (8 sessions, weekly)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 45
Study: 33467878

Group type: EXPERIMENTAL
Intervention: Plasma choline
Number of subjects: 617

Group type: EXPERIMENTAL
Intervention: Plasma betaine
Number of subjects: 617

Group type: EXPERIMENTAL
Intervention: Plasma trimethylamine N‐oxide
Number of subjects: 617
Study: 32027862

Group type: EXPERIMENTAL
Intervention: Siltuximab (11 mg/kg every 3 weeks, extendable to 6 weeks)
Number of subjects: 60
Study: 35778317

Group type: EXPERIMENTAL
Intervention: Mental health training programs
Number of subjects: 33
Study: 33293077

Group type: EXPERIMENTAL
Intervention: Extended Pelvic Lymph Node Dissection (EPLND)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Limited Pelvic Lymph Node Dissection (LPLND)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Extended Pelvic Lymph Node Dissection (EPLND) in ISUP grade groups 3-5
Number of subjects: 300

Group type: COMPARATOR
Intervention: Limited Pelvic Lymph Node Dissection (LPLND) in ISUP grade groups 3-5
Number of subjects: 300
Study: 35926756

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 32494060

Group type: EXPERIMENTAL
Intervention: Active VR (interactive virtual environment)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Passive VR (no interaction possible with the virtual world)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No VR (black screen)
Number of subjects: 30
Study: 35331663

Group type: EXPERIMENTAL
Intervention: Plate model
Number of subjects: 419

Group type: COMPARATOR
Intervention: Counting group
Number of subjects: 419
Study: 33568366

Group type: EXPERIMENTAL
Intervention: Outreach training programme for GPs
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Continuity of care provided by GPs
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Communication training at the ICU-GP interface
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Training in management of long-term complications of sepsis
Number of subjects: 14
Study: 33055072

Group type: EXPERIMENTAL
Intervention: app-based breathing (BioBase)
Number of subjects: 75

Group type: COMPARATOR
Intervention: mindfulness body scan
Number of subjects: 75

Group type: COMPARATOR
Intervention: control
Number of subjects: 75
Study: 35124632

Group type: EXPERIMENTAL
Intervention: Information intervention group (25 participants)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Participatory intervention group (25 participants)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (26 participants)
Number of subjects: 77
Study: 33127212

Group type: EXPERIMENTAL
Intervention: Dexamethasone iontophoresis (1 mg dexamethasone per 1 g administered under the active electrode, intensity of 0.1–0.2 mA/cm2 for ten days)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Physiotherapy program (10 days)
Number of subjects: 46
Study: 33087110

Group type: EXPERIMENTAL
Intervention: STAT model
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Pre-intervention data
Number of subjects: 3000
Study: 34081800

Group type: EXPERIMENTAL
Intervention: Visible alert group
Number of subjects: 446

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Overall impact of BPA
Number of subjects: 446
Study: 33191765

Group type: EXPERIMENTAL
Intervention: Long-acting injectable RPV
Number of subjects: 136
Study: 35321938

Group type: EXPERIMENTAL
Intervention: Over-the-scope-clips (OTSC) therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard endoscopic treatment
Number of subjects: 100
Study: 35368930

Group type: EXPERIMENTAL
Intervention: Donepezil hydrochloride + Resveratrol (RES)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Donepezil hydrochloride (Control Group)
Number of subjects: 90
Study: 33514384

Group type: EXPERIMENTAL
Intervention: Canola oil (25 g/day)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Olive oil (25 g/day)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sunflower oil (25 g/day)
Number of subjects: 72
Study: 32910653

Group type: EXPERIMENTAL
Intervention: Randomized atomic-system generator (RAG) for training data sets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RAG-generated training set
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Molecular-dynamics simulations
Number of subjects: 0
Study: 35395640

Group type: EXPERIMENTAL
Intervention: Alvimopan
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 34563236

Group type: EXPERIMENTAL
Intervention: Early or upfront surgical resection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dopamine agonists (DA) treatment
Number of subjects: 0
Study: 35472586

Group type: EXPERIMENTAL
Intervention: Combined BIS + NOL index monitoring
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard of care monitoring (SOC)
Number of subjects: 60
Study: 34560431

Group type: EXPERIMENTAL
Intervention: Combined whole body vibration and resistance training (RVE)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Strength training alone (RE)
Number of subjects: 23
Study: 35184077

Group type: EXPERIMENTAL
Intervention: Telehealth intervention for family-centered movement activities targeting strength, endurance, executive functioning, and social skills through goal-directed games and activities.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telehealth intervention
Number of subjects: 0
Study: 32390545

Group type: EXPERIMENTAL
Intervention: Cognitive Rehabilitation (CR)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual Treatment (Control)
Number of subjects: 50
Study: 32588030

Group type: EXPERIMENTAL
Intervention: Medical school-based physical activity module
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study: 34798037

Group type: EXPERIMENTAL
Intervention: Etrolizumab 105 mg subcutaneously once every 4 weeks
Number of subjects: 359

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 359
Study: 34247578

Group type: EXPERIMENTAL
Intervention: Singing intervention sessions (n = 59)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (n = 61)
Number of subjects: 120
Study: 35705927

Group type: EXPERIMENTAL
Intervention: MHFA with RBT
Number of subjects: 0

Group type: COMPARATOR
Intervention: MHFA alone
Number of subjects: 0
Study: 33050900

Group type: EXPERIMENTAL
Intervention: Tezepelumab 210 mg administered subcutaneously every 4 weeks for 28 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tezepelumab
Number of subjects: 0
Study: 35780702

Group type: EXPERIMENTAL
Intervention: Delivered daily dinner tray for 6 months with assistance during meals
Number of subjects: 60

Group type: COMPARATOR
Intervention: Regular food
Number of subjects: 60
Study: 32272287

Group type: EXPERIMENTAL
Intervention: Interval training with active recovery (ITAR)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional training (CT)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both ITAR and CT programs
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: ITAR
Number of subjects: 38

Group type: COMPARATOR
Intervention: CT
Number of subjects: 38
Study: 35232755

Group type: COMPARATOR
Intervention: Intravenous thrombolysis with alteplase (IVT) + endovascular treatment (EVT)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) alone
Number of subjects: 600
Study: 34342505

Group type: EXPERIMENTAL
Intervention: Deep learning model for identifying active pulmonary tuberculosis on chest radiographs
Number of subjects: 3327
Study: 32611217

Group type: EXPERIMENTAL
Intervention: AI diagnosis of cancer
Number of subjects: 264

Group type: COMPARATOR
Intervention: Physician diagnosis
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Automated robotic surgery
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Review of medical imaging by AI
Number of subjects: 264
Study: 32097099

Group type: EXPERIMENTAL
Intervention: Cycling training and competition (n = 13)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Recreational cycling (n = 13)
Number of subjects: 26
Study: 32369856

Group type: EXPERIMENTAL
Intervention: Cilostazol-based DAPT
Number of subjects: 918
Study: 34314727

Group type: EXPERIMENTAL
Intervention: Agent drug coated balloon (DCB)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 480
Study: 32464630

Group type: EXPERIMENTAL
Intervention: Dynamic Light Scattering (DLS) sensor at the forehead with SNR cut-off 1.66 in the first group (n = 15)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Dynamic Light Scattering (DLS) sensor
Number of subjects: 31
Study: 36411659

Group type: EXPERIMENTAL
Intervention: Food supplement based on S-adenosyl methionine (SAMe, 200 mg/day) and probiotics (Lactobacillus helveticus Rosell®‐52, Bifidobacterium longum Rosell®‐175, 3 × 10^9 CFU/day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 33848325

Group type: EXPERIMENTAL
Intervention: Flowable Composite (FC) - Filtek Z350XT Flowable Restorative
Number of subjects: 55

Group type: COMPARATOR
Intervention: Packable Composite (PC) - Filtek Z350XT Universal Restorative
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Flowable Composite (FC)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Packable Composite (PC)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Flowable Composite (FC) and Packable Composite (PC)
Number of subjects: 55
Study: 35978339

Group type: EXPERIMENTAL
Intervention: Colostrum acidified to pH 4.0–4.5 (AC)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Untreated pooled colostrum (MC)
Number of subjects: 15
Study: 35196381

Group type: EXPERIMENTAL
Intervention: ACT telephone-delivered coaching
Number of subjects: 1170

Group type: COMPARATOR
Intervention: Standard quitline (QL) telephone-delivered coaching
Number of subjects: 1170
Study: 33004127

Group type: EXPERIMENTAL
Intervention: PCI
Number of subjects: 1652

Group type: COMPARATOR
Intervention: CABG
Number of subjects: 1652
Study: 34488361

Group type: EXPERIMENTAL
Intervention: Surgical treatment (internal anal sphincterotomy)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Traditional treatment
Number of subjects: 250
Study: 32916609

Group type: EXPERIMENTAL
Intervention: Semaglutide 2.4 mg subcutaneously once weekly
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34134591

Group type: EXPERIMENTAL
Intervention: Caffeine (4 mg/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (300 mg of corn-starch)
Number of subjects: 20
Study: 33983065

Group type: EXPERIMENTAL
Intervention: Ivermectin plus doxycycline
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 36235579

Group type: EXPERIMENTAL
Intervention: Olive Pomace Oil (OPO)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Sunflower Oil (SO)
Number of subjects: 68
Study: 33452912

Group type: EXPERIMENTAL
Intervention: Serenoa repens extract (SRE)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 221
Study: 32537717

Group type: EXPERIMENTAL
Intervention: Virtual reality-based exercises
Number of subjects: 30

Group type: COMPARATOR
Intervention: Proprioceptive neuromuscular facilitation
Number of subjects: 30
Study: 35266243

Group type: EXPERIMENTAL
Intervention: Subcutaneous immunoglobulin (SCIG; IgPro20 [Hizentra]) 0.2 g/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subcutaneous immunoglobulin (SCIG; IgPro20 [Hizentra]) 0.4 g/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33483355

Group type: EXPERIMENTAL
Intervention: 8-week educational programme on top of usual treatment
Number of subjects: 329

Group type: COMPARATOR
Intervention: Usual treatment (control)
Number of subjects: 329
Study: 34581424

Group type: EXPERIMENTAL
Intervention: QFR-guided complete revascularization (QFR-G-CR)
Number of subjects: 229

Group type: COMPARATOR
Intervention: IRA-only PCI (control)
Number of subjects: 229
Study: 33692183

Group type: EXPERIMENTAL
Intervention: Scheduled 6-hourly IV acetaminophen for 48 hours post-cardiac surgery
Number of subjects: 900

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 900
Study: 33232356

Group type: EXPERIMENTAL
Intervention: Roommates with higher BMI
Number of subjects: 104
Study: 35881907

Group type: EXPERIMENTAL
Intervention: Colchicine (1 mg before PCI and 0.5 mg daily after until discharge)
Number of subjects: 451

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 451

Group type: COMPARATOR
Intervention: Control
Number of subjects: 451
Study: 33740975

Group type: EXPERIMENTAL
Intervention: Postpartum family planning (PPFP) uptake
Number of subjects: 646

Group type: EXPERIMENTAL
Intervention: Antenatal care wait time
Number of subjects: 646

Group type: EXPERIMENTAL
Intervention: Joint healthcare decision-making
Number of subjects: 646
Study: 33115893

Group type: EXPERIMENTAL
Intervention: Usual care plus a standing frame programme
Number of subjects: 140

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Standing frame programme
Number of subjects: 140
Study: 32074653

Group type: EXPERIMENTAL
Intervention: Computer-assisted total knee arthroplasty with surgical navigation and patellar component positioning
Number of subjects: 20
Study: 32648100

Group type: EXPERIMENTAL
Intervention: Oral co-amoxiclav
Number of subjects: 126

Group type: COMPARATOR
Intervention: Injectable ampicillin and amikacin
Number of subjects: 126
Study: 35202353

Group type: EXPERIMENTAL
Intervention: 4-month regimen containing rifapentine (RPT), moxifloxacin (MOX), isoniazid (INH), and pyrazinamide (PZA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard 6-month regimen for tuberculosis treatment
Number of subjects: 0
Study: 34579763

Group type: EXPERIMENTAL
Intervention: Hishi extract (100 mg/day)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (no extract)
Number of subjects: 64
Study: 34219000

Group type: EXPERIMENTAL
Intervention: Atezolizumab 840 mg with paclitaxel 90 mg/m2
Number of subjects: 651

Group type: COMPARATOR
Intervention: Placebo with paclitaxel 90 mg/m2
Number of subjects: 651
Study: 33086156

Group type: EXPERIMENTAL
Intervention: Communities That HEAL (CTH) intervention
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: CTH intervention
Number of subjects: 67
Study: 33787411

Group type: EXPERIMENTAL
Intervention: Late endovascular treatment in patients with clinical‐ASPECTS mismatch (NIHSS ≥ 10 and ASPECTS ≥ 7, or NIHSS ≥ 20 and ASPECTS ≥ 5)
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Late endovascular treatment in patients without clinical‐ASPECTS mismatch
Number of subjects: 337
Study: 33596340

Group type: EXPERIMENTAL
Intervention: High-Oleic Soybean Oil (HOSBO)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 80:20 blend of HOSBO and fully hydrogenated soybean oil (HOSBO+FHSBO)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 50:50 blend of palm oil and palm kernel oil (PO + PKO)
Number of subjects: 60
Study: 32279030

Group type: EXPERIMENTAL
Intervention: HIIT-then-CR
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: CR-then-HIIT
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: CR-then-HIIT (post-intervention)
Number of subjects: 32
Study: 33400431

Group type: EXPERIMENTAL
Intervention: Head-Mounted Display (HMD)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional ultrasound-guided approach
Number of subjects: 24
Study: 32336008

Group type: EXPERIMENTAL
Intervention: Vandetanib (100 mg once daily)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 34896069

Group type: EXPERIMENTAL
Intervention: EHR-integrated decision tool and supportive interventions
Number of subjects: 212

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 212
Study: 33688714

Group type: EXPERIMENTAL
Intervention: 10% povidone-iodine (PVP-I)
Number of subjects: 17

Group type: COMPARATOR
Intervention: 0.9% NaCl
Number of subjects: 17
Study: 32011502

Group type: EXPERIMENTAL
Intervention: Perpendicular needling
Number of subjects: 48

Group type: COMPARATOR
Intervention: Transverse needling
Number of subjects: 48
Study: 36175936

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate Ringer's solution (BRS)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Sodium lactate Ringer's solution (control group)
Number of subjects: 400
Study: 33896751

Group type: EXPERIMENTAL
Intervention: Transarterial infusion chemotherapy plus microsphere embolization for gastroesophageal cancer and transarterial chemoembolization for hepatic metastasis
Number of subjects: 60

Group type: COMPARATOR
Intervention: Transarterial infusion chemotherapy for gastroesophageal cancer and transarterial chemoembolization for hepatic metastasis
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Transarterial infusion chemotherapy plus microsphere embolization
Number of subjects: 60
Study: 36109083

Group type: EXPERIMENTAL
Intervention: Febuxostat
Number of subjects: 472

Group type: COMPARATOR
Intervention: Control
Number of subjects: 472
Study: 33707990

Group type: EXPERIMENTAL
Intervention: Moderate physical activity program and individual-based counselling intervention
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Moderate physical activity program and group-based counselling intervention
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Group-based intervention
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Individual-based intervention
Number of subjects: 121
Study: 32543683

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Blood Glucose Monitoring (BGM)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: CGM
Number of subjects: 153

Group type: COMPARATOR
Intervention: BGM
Number of subjects: 153
Study: 35164836

Group type: EXPERIMENTAL
Intervention: Motivational interviewing training for GPs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard practice (control group)
Number of subjects: 0
Study: 34639295

Group type: EXPERIMENTAL
Intervention: Chuna manual therapy (CMT) plus usual Korean traditional medicine care for three weeks (6-11 sessions)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Usual care including acupuncture, cupping, herbal medicine, moxibustion, and traditional physiotherapy
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Chuna manual therapy (CMT) plus usual Korean traditional medicine care
Number of subjects: 132
Study: 35304169

Group type: EXPERIMENTAL
Intervention: VIBeS Plus intervention delivered at home by psychologists and physiotherapists focusing on infant development and parental mental health.
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: VIBeS Plus intervention for higher social risk families.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: VIBeS Plus intervention.
Number of subjects: 120
Study: 33167779

Group type: EXPERIMENTAL
Intervention: Machine learning (ML) using support vector machines (SVM) and convolutional neural networks (CNN) trained on ventricular monophasic action potentials (MAPs) to predict sustained ventricular tachycardia/ventricular fibrillation (VT/VF) and mortality.
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Machine learning (ML) using support vector machines (SVM) and convolutional neural networks (CNN) trained on ventricular monophasic action potentials (MAPs) to predict mortality.
Number of subjects: 42
Study: 35561627

Group type: EXPERIMENTAL
Intervention: Maternal multisensory supportive interventions initiated 5 min before and during swaddled bathing.
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group with mothers only present during bathing.
Number of subjects: 48
Study: 34028202

Group type: EXPERIMENTAL
Intervention: Random sequence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random walk sequence
Number of subjects: 0
Study: 36335918

Group type: EXPERIMENTAL
Intervention: Initial invasive strategy added to guideline-directed medical therapy
Number of subjects: 5179

Group type: COMPARATOR
Intervention: Initial conservative strategy
Number of subjects: 5179
Study: 33409923

Group type: EXPERIMENTAL
Intervention: Zinc, Vitamin A, and Magnesium supplementation (30 mg zinc gluconate capsule per day, 250 mg magnesium oxide tablet per day, 25,000 IU vitamin A capsule twice/week for 10 weeks)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo (placebo capsules and tablets for 10 weeks)
Number of subjects: 86
Study: 33324415

Group type: EXPERIMENTAL
Intervention: Hydrogen-rich water 4ml/kg orally three times a day
Number of subjects: 24
Study: 36293881

Group type: EXPERIMENTAL
Intervention: Virtual-reality-based cognitive training (VRCT), 24 sessions, 100 min each, three days/week
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Exercise intervention (aerobic and resistance training), 24 sessions, 60 min each, two times/week for 12 weeks
Number of subjects: 99

Group type: COMPARATOR
Intervention: Exercise intervention
Number of subjects: 99

Group type: COMPARATOR
Intervention: VRCT
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 99
Study: 33758941

Group type: EXPERIMENTAL
Intervention: Elevated risk of iron overload
Number of subjects: 254

Group type: COMPARATOR
Intervention: Typical risk of iron overload
Number of subjects: 254

Group type: COMPARATOR
Intervention: Low iron status genotypes
Number of subjects: 254
Study: 32829945

Group type: EXPERIMENTAL
Intervention: Chronic Resistance (CR) exercise
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Chronic Aerobic (CA) exercise
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Chronic Resistance (CR) + Chronic Aerobic (CA) exercise
Number of subjects: 66